Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Montanova Capital, LLC | 12.44M | $326.0M | 9.90% | +110.0K | 2026-06-30 |
| BlackRock, Inc. | 10.55M | $276.0M | 8.40% | +1.35M | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 9.87M | $258.0M | 7.86% | -- | 2026-06-30 |
| Rubric Capital Management LP | 8.27M | $216.0M | 6.59% | -- | 2026-06-30 |
| Polar Capital Holdings Plc | 6.61M | $173.0M | 5.26% | +940.0K | 2026-06-30 |
| State Street Corp | 5.82M | $152.0M | 4.64% | -473.4K | 2026-06-30 |
| Vanguard Capital Management LLC | 4.99M | $130.0M | 3.97% | +117.2K | 2026-06-30 |
| Morgan Stanley | 4.45M | $116.0M | 3.54% | +232.1K | 2026-06-30 |
| Jennison Associates LLC | 4.22M | $110.0M | 3.36% | -761.7K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 3.95M | $103.0M | 3.14% | +1.45M | 2026-06-30 |
